Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-2224.70	-1292.59	-55.60
Graham Fair Price	-72.16	2438.46	8759.46
PEG	5040.66	0.87	-0.02
Price/Book	19.36	3.13	2.62
Price/Cash Flow	-654.31	-371.92	-49.31
Prices/Earnings	-1414.84	-80.42	-5.31
Price/Sales	8.74	15.47	14.23
Price/FCF	-654.31	-371.92	-49.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.28	0.36	0.39
Operating Margin	75.57	-0.08	-0.32
ROA	92.09	< 0.005	-0.09
ROE	-0.12	< 0.005	92.12
ROIC	-0.08	-0.01	86.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	45.90
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.46	0.73	61.11
EPS QOQ	-3.13	0.92	-70.53
FCF QOQ	-0.29	0.84	187.97
Revenue QOQ	< 0.005	0.09	817.76
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	159.07	151.09	-5.02
Days Sales Outstanding (DSO)	148.95	129.37	-13.14
Inventory Turnover	0.57	0.60	5.28
Debt/Capitalization	0.15	0.15	0.04
Quick Ratio	1.87	1.82	-2.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5258.95	5215.43	-0.83
Cash	1179.45	1129.79	-4.21
Capex	-23.19	-42.67	-84.06
Free Cash Flow	-279.27	-43.83	84.31
Revenue	967.75	1053.51	8.86
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.60	2.64	1.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.18	2.05	1008.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating